10/6/2009

The FDA has granted marketing clearance to Israeli firm KarmelSonix for its WheezoMeter, a device that can quantify the rate of wheezing in asthma patients. The product is already approved in Europe and Australia.

Full Story:
Globes (Israel)

Related Summaries